Yn dangos 391 i 405 o 463 canlyniadau
Joint statement on meeting regulatory standards during periods of global or national shortage of medicines
We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs).
Consultation on our standards for prescribing
We are consulting on changes to our standards for prescribing until Friday 4 January 2019 and we are keen to hear your views